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users. In addition, while the FC has been
positioned both as a contraceptive commodity
and for protection against HIV and STIs,
promotion primarily occurs through the
Reproductive and Child Health Department of
the Ghana Health Service. Aside from services
for commercial sex workers, efforts to integrate
FC promotion within a broader range of
HIV/AIDS programs appear nascent.

The female condom (FC) is the only safe and
effective female-initiated method that provides
simultaneous protection against unintended
pregnancy as well as sexually transmitted
infections (STIs), including HIV/AIDS.1 An
exploratory exercise was conducted by the
Population Council to gain an understanding of
the current and historical landscape of female
condom (FC) procurement, distribution, and
programming in Ghana and to explore the
viability of enhancing national FC promotion.
The exercise was conducted by a Population
Council consultant who interviewed 21 key
stakeholders representing 16 relevant groups or
institutions in Ghana.

Despite the current lull in activity with regard
to FC promotion, interest and nominal support
for it at the policy level are high. This is
evidenced by the FC’s reported inclusion in the
reproductive health and HIV/AIDS policy
frameworks, service provider guidelines, and
revised curricula for in-service training.
Furthermore, the majority of interviewed
stakeholders has a strong belief in the FC’s
potential and feels that greater attention and
resources should be committed to its
promotion. Though stakeholders expressed a
number of concerns about past and current FC
promotion, overall, the exploratory exercise
revealed that the current context and timing
offer a relatively strong window of opportunity
for enhancing promotion of the product in
Ghana. Drawing upon stakeholder suggestions
and synthesis of key observations and findings,
this
report
concludes
with
specific
recommendations for moving forward with an
initiative to enhance FC promotion.

The exercise revealed that a large scale, multipartner launch of the FC occurred in Ghana in
May 2000. The launch was largely successful
in raising product awareness; however, uptake
remained and currently still remains low. Most
stakeholders agree that momentum has waned
substantially since the initial launch and report
that financial support for large scale promotion
and distribution is lacking. Thus, while the
product is reportedly available in both the
public and private sector, social marketing
efforts are virtually absent, pelvic models and
information, education, and communication
(IEC) materials are limited, distribution
primarily occurs in urban areas, and aside from
urban sex workers, programmers have limited
information about current or prospective FC

1

The Population Council has a long-standing interest in the development and introduction of a
range of contraceptive and reproductive health products, particularly those that provide dual protection
against pregnancy and sexually transmitted infections and help expand women’s choices. In line with
this interest, we are currently working in several sub-Saharan African countries to understand and
address the programmatic barriers that hinder access to and use of the female condom (FC) - the only
safe and effective female-initiated method that provides simultaneous protection against unintended
pregnancy as well as sexually transmitted infections, including HIV/AIDS.
Though the female condom is currently available in 108 countries, FC programming
mechanisms and levels of uptake vary considerably. Notably successful programs have been launched
in Brazil, South Africa, Zambia, and Zimbabwe. Research from these and other countries indicates that
effective national promotion of the FC within the context of FP/RH programs has the potential to
expand contraceptive choice and add to the overall method mix.
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The promotion of the female

condom within the context of HIV/AIDS programs (depending on the nature of the epidemic),
provides an additional tool in the HIV prevention tool box. Furthermore, it is anticipated that
successful promotion of the FC can help pave the way for successful introduction of other prospective
female-initiated methods, such as microbicides.
While the FC is currently available in Ghana, uptake is low and a concerted marketing effort is
absent. However, it is believed that the following contextual factors may provide a particularly ripe
environment for successful future promotion: 1) past interest and experience promoting the FC at the
national level; 2) relatively low contraceptive prevalence rate (19% -modern methods);2 3) high unmet
need for family planning (34%)2; and 4) relatively high HIV prevalence among high risk groups (e.g.
24-52% among commercial sex workers).3,4
To explore the viability of enhancing FC programming in Ghana and to gain an understanding
of the current and historical landscape of FC programming, interviews were held with key stakeholders
who have intimate knowledge of the Ghanaian FC context or who otherwise play critical roles in
national reproductive health and HIV/AIDS programming. A complete list of interviewed stakeholders
is provided in Table 1. Individuals and/or organizations were selected on the basis of known
involvement in past or current FC initiatives; snowball sampling was then used to identify additional
stakeholders. Time limitations precluded the involvement of all relevant stakeholders in this initial
exploratory exercise; thus, this sampling is not exhaustive and may be expanded upon as further
interest and efforts emerge.
2

Name
Manju Chetani

Affiliation

Position/Title

Atuahene Kyereme

African Microbicides Advocacy Group
(AMAG)
Freedom From Hunger,
Microbusiness for Health
Ghana AIDS Commission (GAC)

Richard Amenyah

Ghana AIDS Commission (GAC)

Ag. Director, Research, Monitoring,
and Evaluation
Director, Technical Services

Gloria Quansah Asare

Ghana Health Service, Ministry of Health

Ag. Director, Family Health Unit

Rudi Lokko

Ghana Social Marketing Fund (GSMF)

Chief of Operations

Egbert Bruce

JSI/DELIVER

Country Director

Fred Yao Gbagbo

Marie Stopes International (MSI) – Ghana

Clinical Services Manager

Evelyn Quaye

National AIDS Control Programme

Angelina Kodua Nyanor

National AIDS Control Programme

Dan Amaning Danquah

Pharmacy Council

Public Health Nurse,
Care & Support Unit
Senior Public Health Nurse,
Care & Support Unit
Senior Inspecting Pharmacist

Akwasi Boakye-Yiadom

Planned Parenthood Association of
Ghana (PPAG)
Policy, Planning Monitoring and
Evaluation Directorate, Ministry of Health
Population Council/Ghana

Director of Programs

President, SWAA International

Sebastian Eliason

Society for Women and AIDS in Africa
(SWAA)
Society for Women and AIDS in Africa
(SWAA)
United Nations Population Fund (UNFPA)

Mercy Osei-Konadu

United Nations Population Fund (UNFPA)

Emmanuel Essandoh

United States Agency for International
Development (USAID)
United States Agency for International
Development (USAID)
West Africa Program to Combat AIDS
and STI (WAPCAS)

Daniel Mensah

Janet Kwansah
Kobina Bainson
Bernice Heloo
Cecilia Lodonu-senoo

Peter Wondergem
Comfort Adu-Asamoah

3

Coordinator
Social Franchise/Country Manager

Head, Monitoring and Evaluation
Unit
Chief of Party, CHPS-TA

President, SWAA Ghana
National Programme Officer –
Reproductive Health
National Programme Officer
ACCRA/HPNO
HIV/AIDS Advisor
Deputy Executive Director

Stakeholders were asked to discuss a wide range of issues regarding the female condom,
including but not limited to: procurement mechanisms, supply chain, integration within national
policies and strategies, factors affecting demand, service statistics, lessons learned from past promotion
efforts, appropriate positioning and target groups, and views on future promotion and social marketing.
Discussion topics are outlined in Appendix 1. Notes were taken during each interview and later
synthesized to formulate the current report, which aims to outline the historical and current context of
the FC in Ghana, challenges with regard to supply and demand, and stakeholders’ views on enhancing
promotion. The report also offers recommendations for a way forward.

Approved by the U.S. Food and Drug Administration in 1993,5 the FC was officially launched
in Ghana in May 2000 by the Female Condom Planning Committee (FCPC), a collaborative working
group including a wide range of stakeholders listed in Table 2.6,7 The FCPC developed a multi-faceted
strategy for the introduction of the female condom, which primarily involved training of a wide range
of providers and distributors, as well as social marketing, development of information, education, and
communication (IEC) materials, media messaging, and distribution in a variety of public and private
outlets. While there was initially some disagreement about appropriate positioning of the FC, it was
ultimately positioned as a “female controlled” dual protection method. Following initial launch
activities, the United Nations Population Fund (UNFPA) ordered close to one million female condoms
for the Ministry of Health in Ghana.8
Among the many successes of the 2000 launch, the most commonly noted were the exceptional
level of coordination among stakeholders and the effective training of a broad range of clinical and
non-clinical personnel. Most importantly, the 2000 launch was successful in generating widespread
public attention. In fact, 83 percent of all women aged 15-49 in the 2003 Demographic and Health
Survey (DHS) reported having heard of the female condom. This rate is nearly comparable to
awareness of the highly popular injectable and considerably higher than the rates of those having
knowledge about the IUD, implants, or diaphragm. Despite this high level of awareness, uptake of the
method remained relatively low. In the same survey year, 0.8 percent of married women aged 15-49
who had ever used a contraceptive method reported having ever used the female condom, while 0.1
percent reported current use. Use of the female condom was notably higher among sexually active
4

unmarried women, among whom 4.9 and 0.5 percent reported ever use and current use of the female
condom, respectively.2

Trained

International Partners

Local Partners

UNAIDS

Ministry of Health

Doctors

UNFPA

National AIDS Control Program (NACP)

Nurses

Female Health Company

Reproductive and Child Health Unit

Midwives

World Bank

Health Education Unit

Nutritionists

SWAA Ghana (Society for Women and

Health Education Officers

AIDS in Africa – Ghana Chapter)

Pharmacists

Planned Parenthood Association of

Secretaries

Ghana (PPAG)

Nursing tutors

Ghana Social Marketing Foundation

Opinion Leaders

(GSMF).

Pharmacists

Ghana Registered Midwives Association

Chemical Sellers

Canadian International Development

Women’s Groups

Agency (CIDA)

Midwives

Association for Voluntary Surgical

Clinic & Outreach Staff

Providers/Educators

Contraception (AVSC) (now
EngenderHealth)
Society of Private Medical and Dental
Practitioners (SPMDP)
Source: GHS PPT Presentation, obtained from Gloria Asare, Ag. Director, Family Health, GHS

When asked about the limitations of the previous launch, stakeholders noted the following key issues:
•

Lack of sustained commitment and support following the initial burst of activities;

•

Irregular supply at some distribution sites;

•

Primary focus on training providers without an equivalent effort to increase demand
among potential clients;
5

•

Overly generalized marketing efforts, thereby diffusing impact for the most appropriate
target groups;

•

Limited collaboration with and involvement of the mass media; and

•

Minimal operational research conducted to inform the launch and to monitor and
evaluate progress.

It is important to note that the historical context of the female condom in Ghana is rife with
several unverified “truths,” which are commonly circulated among the programming community. One
such “truth” mentioned by several stakeholders is that at one time, sales of the FC were considerably
high, however, the product was not being used as intended. For example, it was repeatedly mentioned
that the inner rings of the FC were used as bangles, which in some communities were dyed and sold.
At one point, this story even gained national media attention. Other unverified “truths” suggest that the
rings were used by seamstresses as reinforcements for clothing and that the FC was primarily
purchased by people from neighboring countries where it was either unavailable or more expensive.
While some stakeholders report having debunked these so-called “truths,” others maintain their
validity. Thus, it remains unclear whether these anecdotes are true (and if so, to what extent), or
whether they are myths that have gained legitimacy through verbal repetition. Regardless of where the
truth lies, the continued circulation of such “truths” can be discouraging for the programming
community and may also undermine the legitimacy of the FC among the general public.

Currently, the FC-1, manufactured by the Female Health Company is reportedly available in
both the public and private sectors in Ghana, however, many stakeholders are doubtful of its
availability in pharmacies. Anecdotal evidence suggests that uptake is minimal and unlikely to have
increased since the 2003 DHS, when only 1 percent of women aged 15-49 who had ever used
contraception, reported having ever used the female condom.2
Most stakeholders agree that momentum has waned substantially since the initial launch of the
FC in 2000 and report that financial support for large scale promotion and distribution is lacking. Thus,
while the product is available, social marketing efforts are virtually absent, pelvic models and IEC
materials are limited, distribution primarily occurs in urban areas, and programmers have limited
information about likely current or prospective FC users. Urban sex workers are the one exception to
6

the latter statement, as they are specifically targeted by the West Africa Project to Combat HIV/AIDS
and STIs. A 2005 research study offers rich information about perceptions, use, and challenges to use
among this group.
While the FC has been positioned both as a family planning commodity and for protection
against HIV/STIs, promotion primarily occurs through the Reproductive and Child Health Department
of the Ghana Health Service. Aside from services for high risk groups such as commercial sex
workers, efforts to integrate FC promotion within a broader range of HIV/AIDS programs appear
nascent. Public health nurses at the National AIDS Control Programme (NACP) note that the female
condom is routinely mentioned in all provider or peer educator trainings, as well as in voluntary
counseling and testing sessions, however, the method is not commonly available for purchase in public
facilities where HIV/AIDS services are offered and is generally overshadowed by the male condom.
Furthermore, some influential stakeholders feel that it is not cost-effective to promote the female
condom for HIV/AIDS prevention.
Several stakeholders expressed disappointment about the current state of affairs with regard to
the FC. One individual mentioned that the situation with the female condom has become “business as
usual,” while another lamented that it is “just hanging.” Another stakeholder commented that people
have not yet “come to grips” with use of the female condom in Ghana. He added that it is being sold
“under the shadow of the male condom.” This sentiment was reinforced by yet another stakeholder
who expressed concern over the fact that the FC “hasn’t been marketed in a big way.” In his opinion,
this is because “those who brought it did not take it as seriously as they should have.”

Despite the apparent lull in FC activity, interest and nominal support of the FC at the policy
level is high. This is evidenced in part by the FC’s reported inclusion in the reproductive health and
HIV/AIDS policy frameworks, service provider guidelines, and revised curricula for in-service
training. Furthermore, with only one exception, interviewed stakeholders expressed strong consensus
about the suitability of the Ghanaian context for further promotion of the female condom and
suggested that greater attention and resources be committed to such an effort. In fact, Gloria Asare, Ag.
Director of the Family Health Unit at the Ghana Health Service (GHS) mentioned that the GHS has
been interested in re-launching both the male and female condom and would welcome any external
support to further such an agenda.
The majority of stakeholders believe that appropriate marketing of the female condom is the
primary area on which future efforts should focus. They are, however, weary of a “one off” type of
7

promotional event, as it is recognized that sustained, long-term commitment is essential for the success
of the FC. Furthermore, stakeholders urged that we maintain realistic expectations about uptake of the
female condom. This method may not be appropriate for everyone and thus we should not expect
uptake to be exceptionally high or comparable to that of the male condom. In addition, it was
suggested that successful promotion will require the “programming community” to acknowledge and
openly discuss the method’s potential drawbacks, rather than brush them aside to focus on other
aspects of programming. Finally, stakeholders cautioned that while local community-based projects
can aid in identifying best practices, advocacy should begin at the government level. In particular, it
was mentioned by one stakeholder that when there is lack of coordination at the national level, the
onus is left to those on the ground – which has not been successful in the past. Another succinctly
stated that “national action paves the way for local action.”

In 2005, the Female Health Company began manufacturing the FC-2, a new model of the
female condom, which is made of nitrile rather than polyurethane. The FC-2 is designed to be less
expensive and to lessen noise during use (a common complaint about the FC-1). At present, facilities
in Ghana only stock the FC-1. However, the FC-2 has recently been registered with Ghana’s Food and
Drugs Board and is expected to comprise all upcoming procurements.

Following the initial launch of the female condom in 2000, the Government of Ghana was the
primary buyer of female condoms in the country, while UNFPA served as the contracting agent for
procurement. However, in 2007, both the government and UNFPA committed funds for the purchase
of 200,000 pieces each - 400,000 pieces in total of the FC-2. All FC supplies are procured through the
Ministry of Health/Ghana Health Service (MOH/GHS), and then supplied to various distributing
agencies through the Central Medical Stores. Primary distributors include the Ghana Social Marketing
Fund (GSMF), Planned Parenthood Association of Ghana (PPAG), and the Ghana Registered
Midwives Association. While GSMF primarily distributes the FC in the private sector (e.g. to chemical
8

sellers), PPAG distributes it through their public clinic facilities, community-based distributors, and
NGOs. Within the Ghana Health Service, the FC is primarily sold at WAPCAS supported STI clinics,
which target commercial sex workers. Sales are virtually absent at the 1,000 or so other GHS clinics.
Figure 1 illustrates the flow of the female condom through the contraceptive commodity supply chain
in Ghana.
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Forecasting for all contraceptive commodities is conducted each year by a core team comprised
of JSI/DELIVER, GHS, GSMF, and PPAG. The most recent forecasting exercise took place in midFebruary 2008. Figure 2 illustrates the trend in FC consumption from 2004 to 2007 and the forecasted
figures for consumption in 2008.9, 10

Figure 2. Actual FC Consumption and 2008 Forecast

Female Condoms Consumed
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Sources: Ghana Contraceptive Forecast Report, 2007; email communication
with Egbert Bruce, Country Director, JSI/DELIVER

Of particular interest in Figure 2 is the forecasted figure for female condom consumption in
2008, which is substantially higher than in previous years. According to Egbert Bruce, Country
Director at JSI/DELIVER, this is primarily due to renewed commitment on the part of key
stakeholders such as the Government of Ghana, Ghana Health Service, UNFPA, and the Ghana Social
Marketing Foundation. Mr. Bruce also notes that stakeholders have a strong belief in the potential for
successful distribution and are hopeful that they will receive external support for an extensive FC
campaign. In addition, the Ghana Social Marketing Foundation did not operate continuously in 2007
and has plans for more regular operation in the upcoming years. It should be noted that promotion and
distribution are currently planned and implemented individually by distributing agencies.
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Stakeholders noted a number of critical issues, which they believe are responsible for low
demand for the female condom:
•

Despite high awareness of the FC in the years following the launch, most people currently have
limited awareness and knowledge of it, since marketing efforts and product visibility have
recently been limited;

•

Minimal efforts are in place to identify and target appropriate sub-groups, so information and
supply points are generalized, not tailored for the most likely prospective users;

•

Though early acceptability studies of the FC in Ghana were positive, many in the provider and
programming communities perceive that acceptability is low due to concerns that the product is
big, messy, noisy, costly, and cumbersome to use;

•

Socio-cultural factors may play a role in dissuading use of the FC. For example, gender
dynamics may limit women’s ability to negotiate use of a female condom, adolescent girls and
women may feel shy to buy the FC for fear of being seen as promiscuous, and females may feel
uncomfortable with the idea of having to touch or guide the penis prior to or during intercourse;

•

High cost of the FC may deter some prospective buyers, especially youth and others with
limited income. Prices vary in the public versus private sector, however, there is at least a 10fold difference in price between male and female condoms.

•

Due to a relatively low national HIV prevalence (2.2%),5 the perceived need for dual protection
is low;

•

Many couples do not view themselves as the intended users of the FC. For example, some see
the FC as a product for commercial sex workers, while others perceive it as something used by
the more educated or “elite.”

•

Many providers have a bias against the FC, often due to negative perceptions about
acceptability and lack of personal experience with the product. Thus, providers are likely not
promoting or championing the product very actively.

Stakeholders generally feel that lack of demand for the FC was a more important problem than
lack of supply. They did, however, note a few key challenges in ensuring efficient functioning of the
drug and contraceptive supply chain. It should be noted that some of these challenges apply to the
broader distribution system and may not be specific to the female condom.
11

First, capacity and infrastructure for logistics management at the facility level is often limited.
Specifically, staff lack computers and appropriate monitoring and evaluation tools for timely and
accurate tracking of supplies. Second, lack of transportation poses a significant obstacle, as most
regions do not have an appropriate vehicle for the delivery of drugs and contraceptive supplies to
facilities. Thus, collection of supplies may be dependent on inconsistent activities, such as travel by
district directors or other staff to meetings in the regional capital. Third, difficulties in receiving
adequate supplies may encourage some facilities to buy them from the open market, where quality and
price may be variable. Fourth, distribution of the female condom has primarily been focused in urban
areas, thus supply in rural districts can be inconsistent and limited. Finally, since the female condom is
only procured through the public sector at a subsidized price, the private sector has the opportunity to
derive a large profit margin. Thus the FC is sold at variable prices. For example, it may be available at
Marie Stopes or a public hospital for 500 Cedis, and cost 1,000 Cedis or more in a pharmacy setting.

Overall, this exploratory exercise has revealed that there is a platform for enhancing promotion
of the female condom in Ghana. The following contextual factors provide a particularly ripe
environment for successful future promotion:
•

Relatively low contraceptive prevalence rate (25% any method; 19% modern
methods);2

•

High unmet need for family planning (34%);2 and

•

High HIV prevalence among high risk groups (24-52% among commercial sex
workers).3,4

Second, the convergence of the following circumstances suggests that timing for enhanced
promotion of the FC is appropriate:
•

The majority of interviewed stakeholders has a strong belief in the product’s potential
and is supportive of focusing greater attention and resources toward its promotion.
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•

The Government and UNFPA are currently in the process of making an exceptionally
large procurement of the FC. They are purchasing over 500,000 pieces – a 6-fold
increase from 2007 to 2008.

•

The upcoming procurement will entirely be comprised of the new model of the female
condom (FC-2). Since this model is expected to be less expensive and more user
friendly (e.g. less noisy during use), its upcoming entry into the health system provides
an ideal opportunity for re-introduction and promotion.

The current Ghanaian context offers a “window of opportunity” to build momentum and initiate a
strong FC promotion agenda. Drawing upon stakeholder suggestions and synthesis of key observations
and findings, the following recommendations offer guidance for moving forward with an initiative to
enhance FC promotion:
1. Conduct a market analysis to determine commercial sustainability of the FC. Given the
historical and current challenges of FC promotion in Ghana, a market analysis should be
conducted so as to identify key target groups and geographic regions as well as to establish
overall commercial sustainability of the product.
2. Allocate or source funds for implementation of a long-tem FC program. Though extensive
funds have been invested in procurement of the FC, past experience shows that product
availability and short-term promotion are inadequate for initiating and sustaining wide-scale
client interest. Commitment to the FC will require sustained political and financial support for
all relevant aspects of product promotion.
3. Establish or designate a committee to develop and implement a strategic plan. In Ghana,
distributors currently develop their own FC distribution plans, however, in light of the large
upcoming procurement of FC and limited public interest in the product, it will be essential to
develop a unified, strategic plan that outlines all relevant activities for promotion and
distribution. Participatory development of a national strategy has been essential to the success
of FC programs in other settings.

A strategic plan could address issues such as key target

groups, promotional strategies and social marketing approaches, training of providers and other
advocates, and implementation of strategies to ensure efficient flow within the distribution and
supply chain. The planning committee could be an existing body, such as the Inter-coordinating
Committee for Contraceptive Security (ICC/CS) or one that is newly designated. It is important
that the committee include diverse representatives from government, NGOs, advocates, civil
society, service delivery, and social marketing.
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4. Review lessons learned. Development of a strategic plan should ensure that key challenges and
weaknesses of both male and female condom promotional efforts in Ghana, as well as in the
broader, global community are understood and well addressed. Despite differing social and
cultural contexts, many of the challenges experienced with regard to male and female condom
promotion are universal.
5. Determine rationale for product promotion and develop strategic plan. Stakeholders should
reach consensus on why the female condom is needed in Ghana and determine the context in
which it will be most effective. This should be used as a basis for developing a strategic plan
and identifying specific target groups. Targeting of specific sub-groups is important, as past
experience shows that generic marketing may diffuse or even counter the impact for the most
likely prospective users. At the same time, it is important to strike a balance between over or
narrowly targeting the product, as this may lead to stigmatism or dissociation.
Exploratory work in the Nkwanta District reveals that adolescents and unmarried young
adults may be a particularly appropriate target group as they are more likely to take interest in
something “new,” may have a greater perceived need for dual protection, and may encounter
fewer socio-cultural barriers to FC use.
6. Ensure contextually appropriate product marketing and messaging. Marketing and messaging
for the FC should be well researched and contextually appropriate. The “women’s
empowerment” angle is likely to be counter-effective in the Ghanaian context as it may
threaten or alienate men. More culturally appropriate messaging might advocate for dual
protection and emphasize the short and long-term benefits for both partners (e.g. pleasurable
sexual experience and safeguarding clients’ future prospects in health, marriage, fertility,
education, and career.
7. Develop innovative social marketing strategies. Research should be conducted to inform the
development of a multi-faceted social marketing plan. Some suggestions offered by
stakeholders to guide this process include: developing local branding and attractive packaging,
collaborating with the mass media, developing culturally appropriate information, education,
communication materials, enlisting popular figures to serve as product “champions,” tapping
into existing communication channels (e.g. youth groups, professional groups, interaction
between women and sellers of feminine hygiene products), and utilizing testimonials from
satisfied users.
8. Move beyond traditional IEC. While traditional IEC materials such as posters and pamphlets
are important for any marketing campaign, successful promotion of the FC will require that
14

targeted clients are well-equipped not only with appropriate knowledge of the product, but also
skills to use it comfortably and effectively (e.g. negotiation with partners and facility in correct
insertion and removal).
9. Identify and address weaknesses in the supply chain. It is critical to avoid stock-outs and ensure
consistent availability of the FC in all areas where the product is promoted, so that client
interest and patronage can be encouraged and sustained.
10. Expand provision beyond urban areas. Previous efforts to launch the FC in Ghana have
primarily focused on urban centers. However, rural promotional efforts carried out by
organizations such as SWAA11 and recent exploratory work carried out by the Population
Council in the Nkwanta District indicate that there is interest and scope for promotion in rural
areas. Discussions in the Nkwanta District indicate that targeting youth or young adults in town
or market centers may be appropriate.
11. Engage civil society actors to expand FC access. Female condoms are primarily available
through clinical providers, and at pharmacy and chemical shops. However, certain barriers (e.g.
poor provider attitudes, distance, early closing times, and embarrassment) may hinder
prospective clients’ patronage of such venues. In order to expand product access, civil society
actors should be engaged to distribute female condoms. Youth and young adults who
participated in exploratory discussions in the Nkwanta District suggested the following as
accessible prospective vendors or distribution sites: hairdressers, barbers, nighttime tea sellers,
provision stores, public transportation centers and vehicles, filling stations, hotels, drinking
bars, restaurants, roadside food sellers, and public toilets.
12. Conduct social behavioral research. It may be necessary to carry out some operational research
in order to inform development of appropriate distribution, education, or marketing strategies
for the FC. Some issues to explore as part of such research might include: methods for
overcoming cultural barriers that currently discourage use of the FC, identifying appropriate
communication channels (existing or new) for specific target groups, debunking myths and
misconceptions that may currently discourage use of the FC, developing appropriate language
and dialogue around the FC, and developing culturally appropriate strategies to involve men in
FC promotion.
13. Target providers first. Providers (e.g. physicians, nurses, and chemical sellers) themselves
appear to have a number of negative perceptions about the female condom, as well as limited
experience using it. Thus, rather than assume that they will be natural allies for FC promotion,
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providers should be regarded as the initial target group. Only when they are true believers, will
providers be effective product champions.
14. Train providers in strategic promotion. Though providers have adequate clinical knowledge
about the FC, they lack training in other aspects that are critical in building and sustaining
client interest in the product. Thus providers should be trained in areas such as: integrating the
FC within education about sexual and reproductive health, selective targeting of client groups,
appropriate positioning for different client groups, use of satisfied client testimonials in
promotional talks, building client capacity to effectively dialogue with partners, and ensuring
clients have the skills and confidence necessary for correct insertion, use, and removal of the
product.
15. Target and involve men in promotion. Men in Ghanaian society are commonly regarded as the
decision-makers; this holds true within the realm of sexual and reproductive health. Thus men’s
support of the FC is critical for encouraging joint-decision making and enhancing women’s
capacity to successfully purchase and/or use it. Exploratory work reveals that promotion among
men might involve an emphasis on both the immediate physical benefits (e.g. greater pleasure
than the male condom since a preference for “skin to skin” contact appears to deter condom
use), as well as on the long term social, health, and financial benefits.
16. Encourage integration within broader context of sexual and reproductive health. Promotion of
the FC should not be centered on the product itself, but rather on meeting the sexual and
reproductive health needs of prospective clients. Accordingly, the FC should be promoted
among key target groups in the context of sexual and reproductive health education, and with
equal emphasis to the male condom.
17. Strengthen FC integration within the context of HIV/AIDS programming. The FC should be
more actively promoted within the context of HIV prevention, voluntary counseling and
testing, and antiretroviral treatment. In particular, it should be made available onsite and
promoted alongside the male condom (given equal weight and attention) as an appropriate
method for dual protection.
18. Develop and implement a monitoring and evaluation plan. It will be essential to develop a
monitoring and evaluation plan, so as to track progress and make necessary adjustments
throughout program implementation. Aside from tracking program outputs and outcomes, it
may also be helpful to address key operational research questions.
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Access, Availability, Acceptability, and Use of the Female Condom in Ghana
•

Is the female condom presently integrated into national health policies (e.g. RH, HIV/AIDS, and
pharmaceutical policies, protocols, and strategies)?

•

Is the female condom currently integrated into service training curricula (e.g. community health nurses,
hospital nurses, physicians)?

•

What factors would you say are affecting the supply of female condoms?

•

What factors would you say are affecting the demand for female condoms?

•

Who (e.g. which organizations, programs, etc.) in the country is procuring female condoms?

•

Do we have any idea of the size of the procurement currently and in the past few years?

•

Is there one centralized system for distribution or several parallel systems? Describe.

•

What is the logistics chain for supply/distribution of female condoms?
o What are the challenges in the functioning of this chain?

•

Who (e.g. projects, organizations, clinics) is distributing female condoms?

•

In which settings is the female condom being distributed?
o
o
o
o

Particular geographic areas?
Particular population groups?
Programmatic/clinical settings (e.g. hospital RH unit, VCT)
Why these settings in particular?

•

Is it possible to get any service statistics and trends on distribution from any of these sources?

•

How is the female condom currently being positioned (e.g. family planning method, protection from
HIV/AIDS, etc)?

•

To what extent and under which circumstances is the female condom being offered?
o Is it discussed in all cases where the male condom is mentioned?
o Is it raised in discussions about family planning or do providers wait for clients to ask about it?
o What is the perception regarding interest and acceptability among users?

•

What are the challenges to introducing, generating interest, or distributing the female condom?

•

What role do you believe the female condom could/should or should not play in Ghana?

•

Do you know of any past, current, or upcoming research studies about the female condom?

•

Do you know of any upcoming plans or projects relating to the female condom?
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